Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Motexafin Gadolinium in Relapsed/Refractory Multiple Myeloma
NCT00096837Phase 2Completed
- Sponsor
- Pharmacyclics
- Modality
- Orthosteric Ligands, Light/Condition-Responsive Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of motexafin gadolinium in multiple myeloma (MM), sponsored by Pharmacyclics. Status: completed.
02
Drugs
motexafin gadolinium
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT00096837.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00096837.